These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10706373)

  • 1. Characterization of 3-epi-1alpha,25-dihydroxyvitamin D3 involved in 1alpha,25-dihydroxyvitamin D3 metabolic pathway in cultured cell lines.
    Masuda S; Kamao M; Schroeder NJ; Makin HL; Jones G; Kremer R; Rhim J; Okano T
    Biol Pharm Bull; 2000 Feb; 23(2):133-9. PubMed ID: 10706373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3 and 1alpha,25-dihydroxy-16-ene-23-yne-20-epi-vitamin D3: analogs of 1alpha,25-dihydroxyvitamin D3 that resist metabolism through the C-24 oxidation pathway are metabolized through the C-3 epimerization pathway.
    Reddy GS; Rao DS; Siu-Caldera ML; Astecker N; Weiskopf A; Vouros P; Sasso GJ; Manchand PS; Uskokovic MR
    Arch Biochem Biophys; 2000 Nov; 383(2):197-205. PubMed ID: 11185554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation.
    Campbell MJ; Drayson MT; Durham J; Wallington L; Siu-Caldera ML; Reddy GS; Brown G
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):169-83. PubMed ID: 10375029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.
    Siu-Caldera ML; Sekimoto H; Weiskopf A; Vouros P; Muralidharan KR; Okamura WH; Bishop J; Norman AW; Uskoković MR; Schuster I; Reddy GS
    Bone; 1999 May; 24(5):457-63. PubMed ID: 10321905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-3 epimerization of vitamin D3 metabolites and further metabolism of C-3 epimers: 25-hydroxyvitamin D3 is metabolized to 3-epi-25-hydroxyvitamin D3 and subsequently metabolized through C-1alpha or C-24 hydroxylation.
    Kamao M; Tatematsu S; Hatakeyama S; Sakaki T; Sawada N; Inouye K; Ozono K; Kubodera N; Reddy GS; Okano T
    J Biol Chem; 2004 Apr; 279(16):15897-907. PubMed ID: 14757768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation, identification and biological activity of 24R,25-dihydroxy-3-epi-vitamin D3: a novel metabolite of 24R,25-dihydroxyvitamin D3 produced in rat osteosarcoma cells (UMR 106).
    Kamao M; Tatematsu S; Reddy GS; Hatakeyama S; Sugiura M; Ohashi N; Kubodera N; Okano T
    J Nutr Sci Vitaminol (Tokyo); 2001 Apr; 47(2):108-15. PubMed ID: 11508700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).
    Siu-Caldera ML; Rao DS; Astecker N; Weiskopf A; Vouros P; Konno K; Fujishima T; Takayama H; Peleg S; Reddy GS
    J Cell Biochem; 2001; 82(4):599-609. PubMed ID: 11500938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced biological activity of 1alpha,25-dihydroxy-20-epi-vitamin D3, the C-20 epimer of 1alpha,25-dihydroxyvitamin D3, is in part due to its metabolism into stable intermediary metabolites with significant biological activity.
    Siu-Caldera ML; Sekimoto H; Peleg S; Nguyen C; Kissmeyer AM; Binderup L; Weiskopf A; Vouros P; Uskoković MR; Reddy GS
    J Steroid Biochem Mol Biol; 1999 Dec; 71(3-4):111-21. PubMed ID: 10659699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of antiproliferative activity of 1alpha,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific.
    Zhao J; Tan BK; Marcelis S; Verstuyf A; Bouillon R
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):197-202. PubMed ID: 8645629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic stability of 3-epi-1α,25-dihydroxyvitamin D3 over 1 α 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1.
    Rhieu SY; Annalora AJ; Wang G; Flarakos CC; Gathungu RM; Vouros P; Sigüeiro R; Mouriño A; Schuster I; Palmore GT; Reddy GS
    J Cell Biochem; 2013 Oct; 114(10):2293-305. PubMed ID: 23606409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
    Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
    Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium.
    Bland R; Walker EA; Hughes SV; Stewart PM; Hewison M
    Endocrinology; 1999 May; 140(5):2027-34. PubMed ID: 10218951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion.
    Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS
    J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly.
    Reddy GS; Robinson M; Wang G; Palmore GT; Gennaro L; Vouros P; De Clercq P; Vandewalle M; Young W; Ling S; Verstuyf A; Bouillon R
    Arch Biochem Biophys; 2007 Apr; 460(2):254-61. PubMed ID: 17196157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells.
    Rehan VK; Torday JS; Peleg S; Gennaro L; Vouros P; Padbury J; Rao DS; Reddy GS
    Mol Genet Metab; 2002 May; 76(1):46-56. PubMed ID: 12175780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D metabolism in human colon adenocarcinoma-derived Caco-2 cells: expression of 25-hydroxyvitamin D3-1alpha-hydroxylase activity and regulation of side-chain metabolism.
    Cross HS; Peterlik M; Reddy GS; Schuster I
    J Steroid Biochem Mol Biol; 1997 May; 62(1):21-8. PubMed ID: 9366495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation.
    Miura D; Norman AW; Mizwicki MT; Fujishima T; Konno K; Kittaka A; Takayama H; Ishizuka S
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):469-79. PubMed ID: 15876412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased biological activity of 20-epi-1,25-dihydroxyvitamin D3 is due to reduced catabolism and altered protein binding.
    Dilworth FJ; Calverley MJ; Makin HL; Jones G
    Biochem Pharmacol; 1994 Mar; 47(6):987-93. PubMed ID: 8147918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-6 functionalized analogs of 25-hydroxyvitamin D3 and 1alpha,25-dihydroxyvitamin D3: synthesis and binding analysis with vitamin D-binding protein and vitamin D receptor.
    Addo JK; Swamy N; Ray R
    Steroids; 1999 Apr; 64(4):273-82. PubMed ID: 10399884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.